ArticleJournal of market access & health policy2019
The impact of non-medical switching among ambulatory patients: an updated systematic literature review.
Article in Journal of market access & health policy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Changes in Medicare Part D coverage in competitive classes in the post-Inflation Reduction Act landscape: 2024-2026.Health affairs scholar · 2026Article
- Brand-to-brand nonmedical switching among interleukin-17 inhibitors or other biologics: Implications of a formulary change.Journal of managed care & specialty pharmacy · 2025Article
- Consensus-Based Overarching Principles and Recommendations on the Use of Biosimilars in the Treatment of Inflammatory Arthritis in the Gulf Region.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2024Article
- Modeling the Effects of Formulary Exclusions: How Many Patients Could Be Affected by a Specific Exclusion?Journal of health economics and outcomes research · 2024Article
- Patient and Clinician Challenges with Anticholinergic Step Therapy in the Treatment of Overactive Bladder: A Narrative Review.Advances in therapy · 2023Review
- Diabetes And The Fragmented State Of US Health Care And Policy.Health affairs (Project Hope) · 2022Article
- Cost and clinical impact of a nonmedical DPP-4 inhibitor switch in patients with diabetes.Journal of managed care & specialty pharmacy · 2021Article
- Switching from one reference biological to another in stable patients for non-medical reasons: a literature search and brief review.Journal of market access & health policy · 2021Article
- Specialist physician perspectives on non-medical switching of prescription medications.Journal of market access & health policy · 2020Article
- The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases.Therapeutic advances in musculoskeletal disease · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.